FROM: B. Hartley TO: Distribution July 22, 1993 RE: RBH NEW BRAND LAUNCH - OXFORD CIGARETTES 0 RSH recently launched a new cigarette innovation under the brand name "Oxford". It is currently in test market in Z locations, London, Ontario and Quebec City. The offering is designed to allow a single cigarette to be extinguished and relit without the negative side effects (i.e. burnt taste) normally associated with refighting. To accomplish this, the filter "twists" into -a new position for the 'second" smoke, presumably ensuring a fresh taste. In addition,, a snipper is included to cut the burnt end off as is a cardboard tube to extinguish and store the cigarette between smoking occasions. All of these items come in a metal carry ing/storage tin which includes 10 cigarettes and sells for between $2.55 and $3.00 at retaiL Oxford 'is offered in both full flavoured and Light versions. Consumer information collected through both qualitative groups and the CMA indicates that Oxford does not appear to be a significant threat. While awareness levels are relatively high, post-trial reaction is quite negative. Based on tracking in London/Quebec City, the following levels of awareness and trial were achieved in the first month of the launch. 1%c BATCo document for Legal Services : Health Canada 20 October 1999 % of Total TM Smokers (n = 97) Oxford Trident (Alta) Awareness 49% 54% Trial 20% 27% Purchase 9% 2916 These numbers are similar to those seen one month after the Trident launch in test market. Several factors help explain this. Regional feedback indicates that RBH has put significant effort into the Oxford launch. Extensive displays are being used, as are demonstrations. The brand has achieved very high levels of distribution in the test market cities. In both Quebec and the Atlantic the product is gaining exposure through radio news broadcasts. In addition, the brand was launched in a tin format, which the Trident exercise showed us has potential to heighten interest in and of itself. in spite of the apparent success of the launch from an awareness perspective, post trial reaction does not bode well for its future. Post-trial satisfaction levels were reported as below: Level of Satisfaction Among Those Who Have Tried Oxford In = 48) M) Totally Satisfied 0 Very 25 ot ery 40 Not At All 35 Among those who were aware of the brand, only a handful of consumers indicate that they would be interested in buying it. ~A C1\ t_^~ (DIN %-Q .Za. BATCo document for Legal Services : Health Canada 20 October 1999 Likelihood To Purchase Within the Next 6 Months M Very Likely 4 Fairly Likely 12 Not Very Likely 16 Not At All Likely 57 Base = Those aware of Oxford When asked why they would not be interested in buying Oxford, the following reasons were given; Prefer own brand 34% Do not like/enjoy Oxford - 38% Too strong - 14% Dislike the gadgetry involved - 16% Burn too long - 9% Price - 9% These results are corroborated by the findings of qualitative research held in London in mid June. Generally, the novelty was appealing but the mechanics seemed inconvenient. The concept appealed to a few smokers who were often in situations where they were not able to finish their cigarettes, but more as a novelty item than as a smoking behaviour to which they were likely to commit long term. In terms of pricelvalue, Oxford's lower absolute price point was a bonus for some. The fact that a premium is paid for Oxford (i.e. $2.75 on average for 10 cigarettes vs $5.50 for 25 regular lights) was, however, not recognized by smokers in the groups. Among those who have tried the brand, the CMA tracker indicates that most people thought it actually offered less value than regular cigarettes (see below). C) U 4 ON k-;-4 ON ~Iz Z~- BATCo document for Legal Services: Health Canada 20 October 1999 How Would You Compare the Value of Oxford to Regular Cigarettes? (%) I Better Value 10 Equal Value 35 Not as Good Value 50 Base = Those who have tried In conclusion then, as a novelty item, Oxford does have limited appeal. Trial has been fairly high and we will monitor it closely - it should drop off quickly if indeed the appeal is based on novelty. In terms of long term viability, Oxford does not appear likely to succeed. Feedback indicates that there have been very few repeat sales of the product at both whole sale and retail. We will continue to monitor Oxford's success and will forward additional information as it become available. Please feel free to call me if you have any questions or comments. U, EH/kr CD L^i 01\ ~-~4 cylll %,0 .9::,. BATCo document for Legal Services : Health Canada 20 October 1999